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Herbal medicine is popularized worldwide due to its ability to cure the diseases with
lesser or no side effects. North Eastern part of India comes under one of the world
biodiversity hotspots which is very rich in traditional herbal medicine. Annona reticulata
L. (Annonaceae) is one such plant used for the treatment of inflammatory diseases,
liver ailments and diabetes by traditional healers. The present study was aimed to
scientifically validate this folk knowledge and to develop an herbal remedy through
evaluating bioactive guided fractions of A. reticulata (AR) bark against hepatotoxicity
and inflammation using in vitro and in vivo models. Results of this study demonstrates
that among all fractions of AR bark, methanol extract and its water fraction possess
strong anti-oxidant ability and showed protection against CCl4 induced toxicity in HepG2
cell lines and rats. Both the fractions also exhibit dose dependent anti-inflammatory
activity against carrageenan induced inflammation in rats. Water fraction showed potent
response in the entire tests conducted than methanol extract, which states that polar
components of the AR bark methanol extract were responsible for these activities.
Further, from the experiments conducted to elucidate the mechanism of action, the
results revealed that AR bark showed liver protection and anti-inflammatory response
through inhibiting the oxidative stress and inflammatory cytokines.
Keywords: antioxidant, liver toxicity, cytokines, inflammation, oxidative stress
INTRODUCTION
Reactive oxygen species (ROS) cause oxidative damage and lipid peroxidation in cells which can
potentially leads to different diseases like cancer, inflammation, aging, heart problem, and severe
liver damage (Ha et al., 2010; Chen et al., 2011). Liver is the second largest organ in the body which
involves in vital functions like cleansing blood, vitamin synthesis, regulation of supply of body fuel,
cholesterol regulation, balancing hormone regulation, and drug metabolism. Different ailments
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like virus, chemicals, and chronic alcoholism cause damage
to the liver by producing vast number of ROS (Hou et al.,
2013). More than 600 chemical substances can cause liver injury,
among all carbon tetra chloride (CCl4), paracetamol and ethanol
are more predominant (Cengiz et al., 2013). Inflammation
caused due to tissue damage through different stimuli like
irritants and pathogen or due to physical injury. There are very
few drugs available in the market for the treatment of liver
ailments and inflammation with fewer side effects despite of its
pharmacological action. In this regard, it is necessary to develop
novel drug candidates with less or no side effects (Huang et al.,
2012). Ayurvedic medicine is so popular worldwide because of
its effective ness and lesser toxicity. Medicinal plants are the
tremendous source of antioxidants and phytochemicals which
have the ability to treat liver aliments and inflammation (Feng
et al., 2011; Pareek et al., 2013). To decrease the side effects by
the synthetic drugs in the market, scientists are now focusing on
developing the herbal based remedy (Kuete and Efferth, 2010).
Antioxidant ability of the plant components can help to
fight against different disease conditions like organ damage;
inflammation and cancer etc., through ROS neutralization inside
the body. Natural antioxidants are safer and healthy than
synthetic antioxidants used in food materials (Su et al., 2009).
Annona reticulata L. (Annonaceae) is a small tree commonly
called as Ramphal, Bullock’s heart and custard apple, native to
India, West Indies and tropical America, mainly cultivated for
fruit production. Traditionally this plant is used as antiparasitic,
insecticide, antidiarrheic, and antidysenteric. Different plant
parts of A. reticulata have been reported for anti-hyperglycemic,
analgesic, cytotoxic, anti-prolifiratory, and CNS depressant
activities (Chavan et al., 2014; Jamkhande and Wattamwar, 2015).
This plant is a good source of different bioactive phytochemicals
like acetogenins (Chang et al., 1998), cycloreticulins A and
B, cyclooctapeptides, cycloreticulin C, glabrin A, cyclopeptides
(Wele et al., 2009; Jamkhande et al., 2016). Stem bark
of this plant contains different chemical constituents like
dopamine, salsolinol, coclaurine, 16-a-hydroxy-(e)-kauran-19-
oic acid, diterpenes (e)-kaur-16-en-19-oic acid, reticullacinone,
methyl-17-hydroxy-16-b-(e)-kauran-19-oate, rolliniastatin and
molvizarin (Hisham et al., 1994; Nirmal et al., 2010; Bhalke and
Chavan, 2011). A substantial amount of population of Assam,
Arunachal Pradesh, and Nagaland of India are using bark of this
plant to cure different liver ailments, inflammation and diabetes.
To scientifically validate this claim and to develop an herbal drug
remedy the present study aims to investigate the bioactive guided
fractions of A. reticulata bark for antioxidant, hepatoprotective
and anti-inflammatory activities using both in vitro and in vivo
models.
MATERIALS AND METHODS
Chemical and Drugs
Cell culture media and related chemical obtained from
Invitrogen, Life Technologies, USA. ELISA kits procured from
R&D Systems, USA. Biochemical kits purchased from Accurex
Biomedical, Pvt. Ltd., Mumbai. All the other chemicals were
analytical grade and obtained from Sigma-Aldrich, Co., St. Louis,
MO, USA.
Plant Collection and Identification
Annona reticulata bark was collected from Kamrup district
(26.3333◦ N, 91.2500◦ E), Assam in the month of January,
2015. Plant was identified by a taxonomist at North East
India Ayurvedic Institute, Guwahati. A voucher specimen
number (1801/IASST/2014-15) was deposited at herbarium,
Drug Discovery Laboratory, Institute of Advanced Study in
Science and Technology for future reference.
Extraction and Bioactive Guided
Fractionation
Annona reticulata bark (ARB) was dried at room temperature
(25–27◦C) and grinded into a coarse powder. 10 kg of the
dried powder was subjected to simple maceration with methanol
for 72 h. The A. reticulata bark methanol extract (ARBME)
was concentrated under pressure using rota evaporator (Buchi,
Switzerland) to yield dry residue of 500 gm. A part of methanol
extract was subjected to gradual fractionation using different
solvents of increasing polarity viz, hexane (ARBHF), chloroform
(ARBCF), ethyl acetate (ARBEAF), and water (ARBWF). Briefly,
400 gm of ARBME was suspended into one liter of hexane and
stirred vigorously by using magnetic stirrer for 24 h at room
temperature. Further the hexane fraction was collected through
filtration and the undissolve residue was collected and dried to
continue the further fractionation. After extracting with all the
solvents, the remaining methanol residue was collected and dried
(ARBMR). The schematic representation of bioactive guided
fraction is shown in Figure 1. Main mother methanol extract and
its five fractions were prepared for testing biological activity and
stored in 4◦C. All the samples were tested within 3 months of
extraction and thawed before use.
In Vitro Antioxidant Activity
DPPH Radical Scavenging Assay
Diphenyl picryl hydrazine (DPPH) assay is widely used method
to determine the ability of phytochemicals to neutralize the
free radicals (Choudhury B. et al., 2016; Kalita H. et al., 2016).
Briefly, 2.7 mL of 0.2 mM DPPH solution was added to 0.3 mL
of the plant extracts/fractions at various concentrations. The
reaction mixture was vigorously shaken and incubated at room
temperature for 1 h; absorbance was measured at 517 nm. The
radical scavenging activity was calculated as follows: scavenging
rate = [(As − Ai)/As] × 100, where As is the absorbance of
pure DPPH and Ai is the absorbance of DPPH in the presence
of various extracts. Ascorbic acid at different concentrations
identical to the experimental samples was used as references.
Reducing Power Assay
The reducing power of the extracts was estimated by following
(Oyaizu, 1986). Increased concentrations of 0.2 mL extracts were
mixed with 2.5 mL of phosphate buffer (0.2 M, pH 6.6) and
2.5 mL of potassium ferricyanide (1%). After incubation at 50◦C
for 20 min, 2.5 mL of trichloroacetic acid (10%) was added, and
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FIGURE 1 | Schematic representation of bioactive guided fractionation of Annona reticulata bark. ARBME, A. reticulata bark methanol extract; ARBHF,
A. reticulata bark hexane fraction; ARBCF, A. reticulata bark chloroform fraction; ARBEAF, A. reticulata bark ethyl acetate fraction; ARBWF, A. reticulata bark water
fraction; ARBMR, A. reticulata bark methanol residue.
each mixture was centrifuged at 1000 rpm for 10 min. Then,
2.5 mL of the supernatant was collected and mixed with 2.5 mL
of deionized water and 0.5 mL of ferric chloride (0.1%). The
absorbance was measured at 700 nm. The increased absorbance
of the reaction mixture indicated increased reducing power. BHT
was used as standards for comparison.
Total Antioxidant Activity
Measurement of total antioxidant capacity of plant extracts
were performed by photochemiluminescence method in the
Photochem instrument, Germany. The lipophilic and hydrophilic
antioxidants were measured with the kits commercially available
from Photochem, Germany. Total antioxidant activity of plant
extracts was expressed in trolox equivalents for lipophilic
antioxidants and ascorbic acid equivalents for hydrophilic
antioxidants.
Cell Culture
Human liver hepatoma cells (HepG2) were obtained from
National Center for Cell Sciences (NCCS), Pune, India. The cells
were seeded 1 × 105 cells/T25 flasks and cultured in DMEM
containing low glucose with 10% FBS and Penstrap (antibiotic
solution) in CO2 Incubator at 37◦C. Stock culture was grown in
25 cm2 culture flasks and all experiments were done in 96 well
plates (Life Technologies, USA).
In vitro Cytotoxicity Assay
Tetrazolium salt assay (MTT) was used to determine the
cytotoxic concentration of plant fractions by following the
method of Kalita S. et al. (2015, 2016) and Kandimalla et al.
(2016). Briefly, the cells from the culture flask was trypsinized
and seeded in 96-well plate at 5× 103 cells/well and incubated in
CO2 incubator at 37◦C for 24 h. After 24 h culture medium was
replaced with new medium and ARBME, ARBWF (5, 25, 50,125,
250, and 500 µg/ml) at different concentrations. After 72 h of
incubation in CO2 incubator at 37◦C, medium was removed and
20 µl of 4 mg/ml MTT (pH 7.4) was added in each well. Plate was
incubated for 4 more hours and the supernatant was removed
and 100 µl of DMSO was added to each well and incubated for
30 min to dissolve the formed formazan. Absorbance was read
at 570 nm by using micro plate reader (ThermoFisher, USA).
The percentage growth inhibition was calculated by using the
following formula:
% Growth inhibition =
100 −
[
Mean OD of individual test group
Mean OD of Control group
]
× 100
Protective Effect of A. reticulata Fractions in CCl4
Induced Toxicity in HepG2 Cell Lines
HepG2 cells at 1 × 105 cells/ml were adjusted with DMEM
medium containing 10% fetal bovine serum. To each well
of 96 well microtiter plate 0.1 ml of diluted cell suspension
was added and incubated at 37◦C for 24 h in CO2 incubator.
After 24 h of incubation the medium was discarded and
expose the cells with different treatments they are as
following:
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Group-I (Control):
Normal control: Cells were treated with 100 µl of serum free
culture medium for 24 h.
DMSO control: Cells were treated with 100 µl of serum free
culture medium containing DMSO (0.25% v/v) for 24 h.
Silymarin Control: Cells were treated with 100 µl of serum free
culture medium containing silymarin (200 µg/ml) for 24 h.
ARBME Control: Cells were treated with 100 µl of serum free
culture medium containing ARBME (200 µg/ml) for 24 h.
ARBWF control: Cells were treated with 100 µl of serum free
culture medium containing ARBWF (200 µg/ml) for 24 h.
Group-II (CCl4 treatment): Cells were treated with 100 µl of
serum free culture medium containing 1.0% (v/v) CCl4 for 24 h.
Group-III (Standard treatment): Cells were treated with 100 µl
of serum free culture medium containing 1.0% (v/v) CCl4 and
silymarin at different concentrations (50, 100, or 200 µg/m) for
24 h.
Group-IV (ARBME treatment): Cells were treated with 100 µl
of serum free culture medium containing 1.0% (v/v) CCl4 and
ARBME at concentration of (50, 100, or 200 µg/m) for 24 h.
Group-V (ARBWF treatment): Cells were treated with 100 µl
of serum free culture medium containing 1.0% (v/v) CCl4 and
ARBWF at concentration of (50, 100, or 200 µg/m) for 24 h.
Cell Viability Assay
Trypan blue exclusion assay (Rambabu and Vijayakumar, 2014)
was performed to determine the cell viability. Briefly, after the
exposure of cells to different treatment the cells from the wells
were trypsinized and centrifuged at 1000 g for 10 min at 40◦C.
The pellet was resuspended in 1 ml ice cold PBS, then 0.1 ml of
cell suspension was mixed with 0.1 ml of 0.2% trypan blue. Viable
cells were counted using hemocytometer under lite microscope.
Percentage of cell viability was calculated using the following
formula-
%viability =
(Total number of cells − Trypan blue stained cells)
Total number of cells
× 100
Measurement of LDH
After the drug treatment, HepG2 cells culture media from all
the treatment groups were centrifuged at 2000 rpm for 15 min
and supernatant was collected to measure the LDH by Ecoline
diagnostic kit. One unit of LDH activity is describe as the amount
of enzyme that catalyzes the conversion of lactate to pyruvate
to produce 1.0 µmol of Nicotinamide adenine dinucleotide
(NADH) per minute.
Acute Toxicity Studies
Acute oral toxicity studies were performed according to OECD
guidelines to test chemicals. Swiss albino mice of either sex (five
animals) was randomly selected were used for this study. Animal
was kept overnight fasting with free access to water but not
food, next day morning single dose of methanolic extract and
active fraction of A. reticulata bark at 2000 mg/kg body weight
were administered orally to three animals each. Animals were
observed for 14 days, if mortality was observed in two out of three
FIGURE 2 | Diphenyl picryl hydrazine (DPPH) radical scavenging
activity of different fractions of A. reticulata bark. ARBME, A. reticulata
bark methanol extract; ARBHF, A. reticulata bark hexane fraction; ARBCF,
A. reticulata bark chloroform fraction; ARBEAF, A. reticulata bark ethyl acetate
fraction; ARBWF, A. reticulata bark water fraction; ARBMR, A. reticulata bark
methanol residue; Vc, ascorbic acid. All the results were expressed in
mean ± SD (n = 3).
FIGURE 3 | Reducing power ability of different fractions of A. reticulata
bark. ARBME, A. reticulata bark methanol extract; ARBHF, A. reticulata bark
hexane fraction; ARBCF, A. reticulata bark chloroform fraction; ARBEAF,
A. reticulata bark ethyl acetate fraction; ARBWF, A. reticulata bark water
fraction; ARBMR, A. reticulata bark methanol residue; BHT, butylated hydroxyl
toluene. All the results were expressed in mean ± SD (n = 3).
animals, then the dose was identified as toxic dose. If mortality
was observed in one animal, experiment was repeat again with
same dose to confirm the toxic dose. If mortality observed again
experiment was continued with low doses (300, 50, and 5 mg/kg
body weight).
Animals
Adult male rats of Wistar strain weighing 150–200 g (Main
experiment) and Swiss albino mice weighing 25–30 g (Acute
toxicity studies) were obtained from the Institute of Advanced
study in Science and Technology (IASST), Guwahati (India).
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Animals were maintained at 24◦C ± 1◦C, with relative humidity
of 45–55% and 12:12 h dark/light cycle and had free access to
standard pellet diet (Provimi Animal Nutrition, Pvt. Ltd., India)
and water throughout the experimental protocol. All experiments
were carried out between 09:00 and 17:00 h. The experimental
protocol was approved by the Institutional Animal Ethics
Committee (IAEC) of IASST, Guwahati (IASST/IAEC/2014-
15/746) and performed in accordance to the guidelines of
Committee for Control and Supervision of Experimentation on
Animals (CPCSEA).
Effect of A. reticulata Active Fraction
against CCl4 Induced Hepatotoxicity
Experimental Design
Adult male Wistar rats Total of 42 animals were randomly
divided into seven groups of six animals in each group. All the
drug treatment was continued for 14 days and on 14th day single
dose of CCl4 1.5 mg/kg, in 1:1 dilution with olive oil was given in
i.p. route.
Group I: Control animals (D.W for 14 days orally).
Group II: Toxic control (0.3% CMC for 14 days orally).
Group III: Standard group (Silymarin 100 mg/kg in 0.3% CMC
for 14 days orally).
Groups IV and V: Treatment groups ARBME at 200 and
400 mg/kg in 0.3% CMC for 14 days orally).
Groups VI and VII: Treatment groups ARBWF at 50 and
100 mg/kg in 0.3% CMC for 14 days orally).
After 48 h of CCl4 administration all the animals was
sacrificed and blood and liver was collected for biochemical
estimation and histopathology analysis.
Biochemical Estimation
Blood was collected from retro-orbital route under mild
anesthesia and allowed to clot and serum was separated by
centrifugation at 3000 rpm for 10 min and stored in −80◦C for
further use. Serum biochemical enzymes like AST, ALT, ALP, and
LDH levels was estimated by commercially available kits from
Accurex, India as per the instructions given by the company.
ELISA kits from R&D Systems, USA was used to measure the
serum TNF-α, IL-1β, and IL-10 levels. Each sample was done in
duplicate and results were expressed in Pg/ml.
Liver Biochemical Assays
Liver homogenate was prepared with 50 mM cold potassium
phosphate buffer (pH 7.4). The resulting suspension was
centrifuged at 3000 rpm for 15 min and supernatant was collected
to measure the super oxide dismutase (SOD), catalase (CAT) by
using assay kits from Cayman, USA as per the instructions given
by the manufacturer and thiobarbituric acid reacting substances
(TBARS) by Xia et al. (2013).
Histopathology Examination
Liver tissues were collected in 10% buffered formaldehyde from
animals in different treatment groups and preserved at least
for 24 h. After dehydration gradually with ethanol (70–100%),
tissue was cleared in xylene and embedded in paraffin to make
blocks. Sections (5 µm) was prepared by a Leica RM 2016
rotary microtome (Leica Instruments, Ltd., Shanghai, China) and
stained with hematoxylin and eosin. Slides were examined under
microscope (Leica Microsystems Digital Imaging, Germany)
at 10x magnification to observe the histopathological changes
(Bhardwaj et al., 2016; Choudhury A.J. et al., 2016).
Effect of A. reticulata Fractions against
Carrageenan Induced Paw Edema
Thirty six male adult wistar rats were randomly divided into six
groups of six animals in each group. Animals kept overnight
fasting with free access to water. Inflammation was induced in
animals by injecting 0.05 ml of 1% carrageenan (Intraplantar
route) to right hind paw. Following drug treatment was given to
the animals 1 h prior to carrageenan injection:
Group I: Control animals (0.3% CMC orally).
Group II: Treatment with 10 mg/kg indomethacin orally.
Groups III and IV: Treatment with ARBME 200 and 400 mg/kg
orally.
Groups V and VI: Treatment with ARBWF 50 and 100 mg/kg
orally.
Paw volume was measured at 0, 1, 3, and 5 h after the induction
of inflammation by water plethysmometer (Harvard apparatus,
Panlab, Spain). After taking the readings, blood was collected to
measure the serum inflammatory markers and all the animals
were sacrificed.
Measurement of Inflammatory Cytokine Levels
Blood was centrifuged at 1000 rpm for 10 min to separate the
serum. Serum inflammatory cytokines like TNF-α, Il-1β, and IL-
10 levels were measured using commercially available kits from
R&D Systems, USA by following manufactures guidelines. All the
experiments were carried out at 4◦C and results were presented in
pg/ml.
Statistical Analysis
All the results were expressed as mean ± SD. One way ANOVA
followed by Tukey’s multiple comparison tests was used to
compare the different parameters between the groups. A P-
value < 0.05 was considered as significant. Graphpad prism 6
software was used to perform the statistical analysis.
RESULTS AND DISCUSSION
In Vitro Anti-oxidant Activity of
A. reticulata Fractions
DPPH Assay
This assay is based on the ability of the substance to reduce
the stable DPPH free radical to DPPH. Scavenging ability of the
antioxidant substance on DPPH is widely accepted method (Liu
et al., 2013). The scavenging ability of the A. reticulata extract and
fractions were given in Figure 2. All the fractions exhibited dose
dependent radical scavenging ability. Among all the fractions
ARBWF showed maximum response and ARBHF showed the
lowest response. From these findings it is suggested that both
ARBME and ARBWF have strong antioxidant property.
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Reducing Power Assay
Reducing power of the substance directly related with its
antioxidant ability (Meir et al., 1995). To measure the reducing
ability, transformation of Fe3+ to Fe2+ was taken into the
consideration, which can be measured spectrophotometrically.
Reducing power ability of A. reticulata extract and fractions were
increased directly proportional to the concentration (Figure 3).
ARBME and ARBWF showed promising results, where water
fraction showed potent response. Among all the fractions tested
ARBME and ARBWF showed potent renounce, so we further
evaluated the biological activity of only these two fractions.
Total Antioxidant Activity
Photo-chemi-luminescence method in the Photochem
instrument was dependent on the antioxidant concentration
based on the Guldberg-Waage law, which expresses the
magnitude of the reaction. Reactions of radicals with antioxidants
give relatively stable products which are measurable. Antioxidant
capacity of the drug/substance depends on the concentration
(Hic and Balic, 2012). Total antioxidant activity of methanol
extract and water fraction of A. reticulata bark found to be
57.34 nmol trolax equivalents and 87.16 nmol ascorbic acid
equivalents respectively.
TABLE 1 | Protective effect of ARBME and ARBWF against CCl4 intoxicated HepG2 cell lines.
Group no. Treatment % Cell viability LDH (U/L)
1 Group-I Normal control 99.42 ± 0.26 96.64 ± 1.67
DMSO control (0.25% V/V) 98.19 ± 0.18 95.47 ± 1.45
Silymarin control (200 µg/ml) 98.56 ± 0.21 97.18 ± 1.58
ARBME (200 µg/ml) control 98.07 ± 0.19 97.73 ± 1.76
ARBWF (200 µg/ml) control 97.84 ± 0.22 96.29 ± 1.41
2 Group-II Toxin CCl4 control (1% v/v) 19.72 ± 0.26∧ 197.64 ± 3.38
3 Group-III Silymarin 50 µg/ml + CCl4 (1% v/v) 68.22 ± 0.21∗ 123.37 ± 2.19∗
Silymarin 100 µg/ml + CCl4 (1% v/v) 76.47 ± 0.18∗ 115.42 ± 2.35∗
Silymarin 200 µg/ml + CCl4 (1% v/v) 88.39 ± 0.24∗ 106.42 ± 1.84∗
4 Group-IV ARBME 50 µg/ml + CCl4 (1% v/v) 39.64 ± 1.20∗ 182.71 ± 2.46∗
ARBME 100 µg/ml + CCl4 (1% v/v) 45.27 ± 1.23∗ 159.65 ± 2.21∗
ARBME 200 µg/ml + CCl4 (1% v/v) 52.66 ± 1.17∗ 142.56 ± 1.87∗
5 Group-V ARBWF 50 µg/ml + CCl4 (1% v/v) 47.25 ± 1.26∗ 151.19 ± 1.49∗
ARBWF 100 µg/ml + CCl4 (1% v/v) 56.17 ± 1.21∗ 138.24 ± 2.17∗
ARBWF 200 µg/ml + CCl4 (1% v/v) 64.42 ± 0.95∗ 129.68 ± 1.41∗
All the results were expressed in mean ± SD (n = 3). ∧P < 0.05 in comparison of group-II with group-I. ∗P < 0.05 in comparison of groups-III, IV, and V with group-II.
ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction.
TABLE 2 | Effect of different drug treatment on serum and liver enzyme levels of CCl4 intoxicated rats.
Group no. Group Serum levels of Liver levels of
AST (IU/l) ALT (IU/l) ALP (IU/l) LDH (U/l) SOD (U/ml) CAT
(nmol/min/ml)
TBARS (nmol/g
tissue)
1 Control 41.6 ± 2.8 38.3 ± 2.4 94.5 ± 3.2 436.8 ± 15.4 9.8 ± 1.1 5.2 ± 0.8 158.5 ± 8.7
2 CCl4 treatment
(1.5 ml/kg)
124.2 ± 6.1$$$ 96.7 ± 5.8$$$ 197.5 ± 9.7$$$ 1022.9 ± 29.2$$$ 1.9 ± 0.4$$$ 0.8 ± 0.1$$$ 342.8 ± 12.6$$$
3 Silymarin
(100 mg/kg) +
CCl4 (1.5 ml/kg)
52.8 ± 4.4∗∗∗ 44.6 ± 3.5∗∗∗ 108.2 ± 7.8∗∗∗ 471.4 ± 20.6∗∗∗ 7.7 ± 0.8∗∗∗ 4.6 ± 0.5∗∗∗ 171.8 ± 9.4∗∗∗
4 ARBME 200 mg/kg
+ CCl4 (1.5 ml/kg)
72.7 ± 5.3∗∗∗ 59.9 ± 3.8∗∗∗ 132.4 ± 7.2∗∗∗ 563.8 ± 18.5∗∗∗ 3.8 ± 0.7∗∗∗ 3.2 ± 0.4∗∗ 213.4 ± 11.8∗∗∗
5 ARBME 400 mg/kg
+ CCl4 (1.5 ml/kg)
63.4 ± 4.8∗∗∗ 53.4 ± 4.1∗∗∗ 121.8 ± 9.6∗∗∗ 509.4 ± 16.6∗∗∗ 5.6 ± 1.1∗∗∗ 3.9 ± 0.6∗∗∗ 186.1 ± 8.6∗∗∗
6 ARBWF 50 mg/kg
+ CCl4 (1.5 ml/kg)
67.6 ± 5.4∗∗∗ 53.9 ± 4.7∗∗∗ 126.9 ± 8.5∗∗∗ 530.7 ± 19.2∗∗∗ 5.1 ± 0.9∗∗∗ 3.8 ± 0.4∗∗∗ 194.5 ± 9.7∗∗∗
7 ARBWF 100 mg/kg
+ CCl4 (1.5 ml/kg)
57.3 ± 3.9∗∗∗ 45.1 ± 3.6∗∗∗ 111.2 ± 8.8∗∗∗ 494.3 ± 21.2∗∗∗ 6.8 ± 0.9∗∗∗ 4.5 ± 0.7∗∗∗ 178.6 ± 10.5∗∗∗
All the results were expressed in mean ± SD (n = 6). $$$P < 0.001 in comparison of CCl4 alone treated animals with normal animals. ∗∗∗P < 0.001 and ∗∗P < 0.01 in
comparison of drug treated animals with CCl4 alone treated animals. ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction.
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FIGURE 4 | Effect of different drug treatment on serum TNF-α levels. All the results were expressed in mean ± SD (n = 6). $$$P < 0.001 in comparison of
CCl4 alone treated animals with normal animals. ∗∗∗P < 0.001, ∗∗P < 0.01, and ∗P < 0.05 in comparison of drug treated animals with CCl4 alone treated animals.
ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction.
FIGURE 5 | Effect of different drug treatment on serum IL-1β levels. All the results were expressed in mean ± SD (n = 6). $$$P < 0.001 in comparison of CCl4
alone treated animals with normal animals. ∗∗∗P < 0.001 and ∗∗P < 0.01 in comparison of drug treated animals with CCl4 alone treated animals. ARBME,
A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction.
Cytotoxicity Effect of ARBME and ARBWF in HepG2
Cells
Both ARBME and ARBWF did not show significant difference
on percentage growth inhibition up to 250 µg/ml. At large dose
500 µg/ml both the fractions showed growth inhibits the HepG2
cell growth, so we selected 50, 100, and 200 µg/ml to evaluate the
hepato protective response of ARBME and ARBWF.
Cytoprotective Effect of ARBME and ARBWF in CCl4
Induced Toxicity on HepG2 Cells
Table 1 shows the effect of different drug treatments on CCl4
intoxicated HepG2 cell lines. On exposure to CCl4 cell viability
was significantly decreased and LDH levels were significantly
raised. Cells on treatment with ARBME and ARBWF showed
protection from CCl4 dose dependently which can be confirmed
by increased in cell viability and decreased LDH levels. HepG2
cell model is widely used model to study hepatoprotective
activity of xenobiotics, because of its resemblance to human
hepatocytes (Krithikaa et al., 2009). The extent of damage to
cells on exposure to CCl4 was determined by measuring the
cell leakage enzyme like LDH. Here in this study LDH levels
were significantly decrease and cell viability increased in ARBME
and ARBWF treated groups compared to CCl4 alone treated
group. This in vitro result explains the hepatoprotective activity
of the ARBME and ARBWF, water fraction of methanol extract
showed potent activity than methanol extract. Both ARBME and
ARBWF was found to be non-toxic toward HepG2 cells, we
further evaluated its activity in in vivo models.
Frontiers in Pharmacology | www.frontiersin.org 7 June 2016 | Volume 7 | Article 168
fphar-07-00168 June 22, 2016 Time: 11:44 # 8
Kandimalla et al. Effect of A. reticulata on Liver Toxicity and Inflammation
FIGURE 6 | Effect of different drug treatment on serum IL-10 levels. All the results were expressed in mean ± SD (n = 6). $$$P < 0.001 in comparison of CCl4
alone treated animals with normal animals. ∗∗∗P < 0.001, ∗∗P < 0.01, and ∗P < 0.05 in comparison of drug treated animals with CCl4 alone treated animals.
ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction.
FIGURE 7 | Effect of drug treatment on liver histopathology of CCl4 intoxicated rats. (A) Liver of control rat with no CCl4 treatment showing normal
hepatocytes with no inflammatory cell infiltrate; x10. (B) Liver of rat treated with CCl4 showing formation of bridging necrosis with chronic inflammatory cells; x10.
(C) Liver of rat treated with CCl4 and 100 mg/kg silymarin showing normal hepatocytes with no inflammation and necrosis; x10. (D) Liver of rat treated with CCl4
and 400 mg/kg of ARBME showing mild periportal inflammation and no necrosis; x10. (E) Liver of rat treated with CCl4 and 100 mg/kg ARBWF showing absence of
inflammatory cells or necrosis; x10. ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction.
Acute Toxicity Studies
ARBME and ARBWF at 2000 mg/kg did not show any effect
on respiratory rate, heart rate, body temperature, salivation,
corneal reflex, locomotor activity, body tone, skin tone, grip
strength, abdominal tone, tremors, piloerection, tail elevation,
twitches, and convulsions are also not observed. No mortality
was observed after 14 days of observation period in tested mice.
ARBME and ARBWF were found to be non-toxic to animals, so
we further evaluated the hepatoprotective and anti-inflammatory
activity of same using appropriate animal models.
Hepatoprotective Activity of ARBME and
ARBWF against CCl4 Induced Hepatic
Damage
Effect of Drug Treatment on Serum Hepatobiliary
Enzyme Levels
Hepato toxins cause damage to the plasma membrane of
hepatocytes and cause liver toxicity. CCl4 is well-known
hepatotoxic to induce liver damage in laboratory animals. Active
metabolite (CCl3•) is mainly associated with hepatotoxicity
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FIGURE 8 | Effect of A. reticulata bark fractions on carrageenan induced paw edema over 5 h. All the results were expressed in mean ± SD (n = 6). S
P < 0.05 in comparison of drug treated animals with saline treated animals. ARBME, A. reticulata bark methanol extract; ARBWF, A. reticulata bark water fraction.
FIGURE 9 | Effect of different drug treatment on serum IL-1β levels of carrageenan induced paw edema rats. All the results were expressed in mean ± SD
(n = 6). ∗∗∗P < 0.001 and ∗P < 0.05 in comparison of drug treated animals with saline treated animals. ARBME, A. reticulata bark methanol extract; ARBWF,
A. reticulata bark water fraction.
induced by CCl4. This (CCl3•) radical covalently binds with
sulfhydryl groups of protein thiols in hepatocytes and cause
lipid peroxidation and necrosis. During this necrotic stage
hepatobiliary enzymes releases into blood circulation, which
shows increase levels in serum (Vuda et al., 2012). CCl4 alone
treated animals showed raised levels of all serum biochemical
markers. Standard drug silymarin, ARBME and ARBWF restored
the elevated levels of serum AST, ALT, ALP, and LDH levels
due to CCl4 toxicity. ARDWF showed more potent activity than
ARBME, but the response is not up to standard drug activity. The
results of hepatoprotective activity of ARBME and ARBWF were
summarized in Table 2.
Effect of Drug Treatment on Lipid Peroxidation and
Liver Anti-Oxidant Enzymes
Thiobarbituric acid reacting substances are the end products of
lipid peroxidation, high levels of these substances inside the body
is a marker to liver injury. SOD and catalase are the antioxidant
defense enzymes that protect liver from free radicals and inhibit
the lipid peroxidation. CCl4 treatment cause significant decrease
in these antioxidant enzymes and cause the lipid peroxidation
(Cheng et al., 2013). Treatment with standard drug silymarin,
ARBME and ARBWF significantly increases the levels of SOD
and catalase and inhibits the lipid peroxidation (Table 2). Results
of this study clearly demonstrate the hepatoprotective activity
of ARBME and ARBWF. The water fraction (ARBWF) showed
potent response than methanol extract (ARBME), which states
that polar compounds of A. reticulata bark was responsible for
the hepatoprotective response.
Effect of Drug Treatment on Cytokine Levels
CCl4 induction activates inflammatory cytokines TNF-α, IL-1β
and decrease anti-inflammatory cytokine IL-10 levels in in vivo
system. CCl4 metabolism stimulated the Kupffer cells which
activates this TNF-α and IL-1β. IL-1β is strong inflammatory
cytokines which involves in the production of prostaglandins,
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FIGURE 10 | Effect of different drug treatment on serum TNF-α levels of carrageenan induced paw edema rats. All the results were expressed in
mean ± SD (n = 6). ∗∗∗P < 0.001 and ∗P < 0.05 in comparison of drug treated animals with saline treated animals. ARBME, A. reticulata bark methanol extract;
ARBWF, A. reticulata bark water fraction.
macrophage activation and neutrophil infiltration. This
activation of inflammatory cytokine cascade produces significant
damage to the liver cells (Edwards et al., 1993; Ishiyama et al.,
1995). Pretreatment with standard drug silymarin, ARBME and
ARBWF before CCl4 induction significantly inhibits the TNF-α
(Figure 4), IL-1β (Figure 5) production and IL-10 (Figure 6)
destruction in animals. ARBWF showed potent response to
ARBMF which confirms that polar compounds of ARB possess
anti-inflammatory activity mediated hepatoprotective response.
Effect of Drug Treatment on Histopathology of CCl4
Intoxicated Rat Liver
In support to the hepatoprotective activity of ARBME and
ARBWF, histopathology of liver tissue was performed and
analyzed. Liver tissue of control animals showed normal
hepatocytes with no inflammatory cell infiltrate (Figure 7A).
CCl4 intoxication causes demolishment of hepatocytes
which was evidenced by formation of bridging necrosis,
collagen accumulation, large septa and chronic inflammation
(Figure 7B). Standard drug silymarin treated group, ARBME
(400 mg/kg) and ARBWF (100 mg/kg) pretreated animals
showed significant protection from the CCl4, where normal
tissue architecture with no necrosis and mild inflammation was
observed (Figures 7C–E). From this evidence the present study
confirms the hepatoprotective ability of ARB. Compared to
ARBME the dose of ARBWF is less which states that, the later
one is potent than earlier.
Effect of Drug Treatment on
Carrageenan Induced Paw Edema
Paw Volume
Carrageenan induced inflammation in experimental animals
is the widely used model to test the orally injected anti-
inflammatory agents/drugs. Inflammation process takes place in
two phases, in initial phase histamine and serotonin releases
and second phase involves the activation of prostaglandins and
lysosomal bodies which are the prime target of most of anti-
inflammatory agents (Marroquin-Segura et al., 2009). Standard
drug indomethacin, ARBME and ARBWF significantly decrease
the carrageenan induced paw edema in rats (Figure 8) Further
ARBWF showed potent response to ARBME which demonstrate
that polar chemical components of ARB were responsible for this
action.
Serum Cytokine Levels
As discussed previously pro inflammatory cytokines like IL-1β
and TNF-α plays a major role in inflammation process through
activation of the prostaglandin and macrophages. Carrageenan
injection cause notable rise in IL-1β and TNF-α levels and
standard drug indomethacin, ARBME and ARBWF treated
animals inhibits the production of these cytokines (Figures 9
and 10). Our findings demonstrate the anti-inflammatory ability
of ARB.
CONCLUSION
The present study demonstrates the antioxidant,
hepatoprotective and anti- inflammatory ability of bioactive
guided fractions of A. reticulata bark. Methanol extract of
ARB and its water fraction showed strong antioxidant activity
and hence further evaluated for biological activity. Both the
fractions exhibited significant hepatoprotection and anti-
inflammatory response in both in vitro and in vivo studies. The
phyto constituents of ARB potentially reduced the oxidative
stress and inflammatory cytokines to yield the therapeutic
response. ARBWF showed potent response in all the tests
conducted, so from this study it can be concluded that polar
chemical components of A. reticulata bark like 16-a-hydroxy-
(e)-kauran-19-oic acid, diterpenes (e)-kaur-16-en-19-oic acid,
reticullacinone, methyl-17-hydroxy-16-b-(e)-kauran-19-oate,
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rolliniastatin and molvizarin might be responsible for the
obtained pharmacological activity. ARBWF can be used to
prepare the herbal formulations for the treatment of liver
aliments and inflammation related diseases. Successful isolation
and biological screening of the chemical component responsible
for the activity can potentially contribute toward development of
novel drug entity which is undergoing in our laboratory.
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